E-LIB Suche - Ergebnisse für: Hubel, Kai

1

Reduced intensity versus myeloablative conditioning for MDS..:

Niederwieser, Christian ; Iacobelli, Simona ; Franke, Georg-Nikolaus...
Bone Marrow Transplantation. 59 (2024) 8 - p. 1084-1091 , 2024

Link: https://doi.org/10.1038/..

2

Optimizing Real-World Outcomes in High-Risk Relapsed/Refrac..:

Hübel, Kai
Oncology and Therapy. 12 (2024) 2 - p. 217-221 , 2024

Link: https://doi.org/10.1007/..

3

Other B- and T-Aggressive Lymphomas and Lymphomas Associate..:

, In: The EBMT Handbook,

Hübel, Kai ; Montoto, Silvia ; Güven, Mustafa. - p. 791-797 , 2024

Link: https://doi.org/10.1007/..

4

Obinutuzumab Can Be Administered as a 90-minute Short Durat..:

Canales, Miguel A. ; Buchholz, Thomas A. ; Bortolini, Jaisson A.P....
HemaSphere. 7 (2023) 4 - p. e860 , 2023

Link: https://doi.org/10.1097/..

5

Geschlechtsspezifische Unterschiede in Vorerkrankungen, der..:

Profazi, Carla , 2022

Link: https://nbn-resolving.de..

6

IBCL-123 inMIND: A Phase 3 Study of Tafasitamab Plus Lenali..:

Sehn, Laurie H. ; Hubel, Kai ; Luminari, Stefano...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S385-S386 , 2022

Link: https://doi.org/10.1016/..

7

Lymphoma: New Diagnosis and Current Treatment Strategies:

Hübel, Kai
Journal of Clinical Medicine. 11 (2022) 6 - p. 1701 , 2022

Link: https://doi.org/10.3390/..

8

Poster: IBCL-123 inMIND: A Phase 3 Study of Tafasitamab Plu..:

Sehn, Laurie H. ; Hubel, Kai ; Luminari, Stefano...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S172 , 2022

Link: https://doi.org/10.1016/..

9

IBCL-131: inMIND: A Phase 3 Study of Tafasitamab + Lenalido..:

Sehn, Laurie H. ; Scholz, Christian W. ; Luminari, Stefano...
Clinical Lymphoma Myeloma and Leukemia. 21 (2021) - p. S402 , 2021

Link: https://doi.org/10.1016/..

10

Poster: IBCL-131: inMIND: A Phase 3 Study of Tafasitamab + ..:

Sehn, Laurie H. ; Scholz, Christian W. ; Luminari, Stefano...
Clinical Lymphoma Myeloma and Leukemia. 21 (2021) - p. S246 , 2021

Link: https://doi.org/10.1016/..

11

Correction to: The Changing Landscape of Lymphoma Associate..:

Hübel, Kai
Current Oncology Reports. 23 (2021) 10 - p. , 2021

Link: https://doi.org/10.1007/..

12

Final Results of a Phase I/II Trial of the Combination Bend..:

Hess, Georg ; Wagner, Karola ; Keller, Ulrich...
HemaSphere. 4 (2020) 3 - p. , 2020

Link: https://doi.org/10.1097/..

13

Controversies in the Treatment of Follicular Lymphoma:

Hübel, Kai ; Ghielmini, Michele ; Ladetto, Marco.
HemaSphere. 4 (2020) 1 - p. , 2020

Link: https://doi.org/10.1097/..

14

The Changing Landscape of Lymphoma Associated with HIV Infe..:

Hübel, Kai
Current Oncology Reports. 22 (2020) 11 - p. , 2020

Link: https://doi.org/10.1007/..

15

Biosimilars in oncology: Effects on economy and therapeutic..:

Hübel, Kai ; Kron, Florian ; Lux, Michael Patrick
European Journal of Cancer. 139 (2020) - p. 10-19 , 2020

Link: https://doi.org/10.1016/..